Effectiveness of Interventional Therapy for Non-Flow-Limiting Vulnerable Plaques

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

2,190

Participants

Timeline

Start Date

October 1, 2025

Primary Completion Date

September 1, 2027

Study Completion Date

September 1, 2027

Conditions
Coronary Arterial Disease (CAD)Vulnerable Coronary PlaquesThin-cap fIbroatheromaAcute Coronary Syndromes (ACS)
Interventions
PROCEDURE

PCI strategy

-In the intervention group, vulnerable plaque lesions (quantitative flow ratio, QFR \>0.8) to be treated at the operator's discretion using second-generation drug eluting stent (DES).

DRUG

OMT strategy

"* Lifestyle modifications and intensive medical therapy (based on current guideline-directed secondary prevention).~* Both groups to receive statin or other therapies to achieve LDL-C \<1.4 mmol/L and decrease by 50% compared to the baseline.~* Lifestyle and risk factor management to include smoking cessation, nutritional optimization, physical activity, adherence to prescribed medications, and control of diabetes and hypertension."

Trial Locations (1)

100000

Beijing Anzhen Hospital, Beijing

All Listed Sponsors
lead

Beijing Anzhen Hospital

OTHER